UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors

Annals of oncology, 2022-10, Vol.33 (10), p.1041-1051

2022

Link zum Volltext

Verfügbarkeit prüfen

Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance

Annals of oncology, 2021-11, Vol.32 (11), p.1381-1390

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of acetaminophen on the efficacy of immunotherapy in cancer patients

Annals of oncology, 2022-09, Vol.33 (9), p.909-915

2022

Link zum Volltext

Verfügbarkeit prüfen

High levels of TNFα in patients with COVID-19 refractory to tocilizumab

European journal of cancer (1990), 2021-05, Vol.149, p.102-104

2021

Link zum Volltext

Verfügbarkeit prüfen

Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy

European journal of cancer (1990), 2017-04, Vol.75, p.308-309

2017

Link zum Volltext

Verfügbarkeit prüfen

Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?

Annals of oncology, 2021-07, Vol.32 (7), p.936-937

2021

Link zum Volltext

Verfügbarkeit prüfen

Clonal haematopoiesis: A concise review

La revue de medecine interne, 2019-10, Vol.40 (10), p.684

2019

Link zum Volltext

Verfügbarkeit prüfen

Incidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy

Annals of oncology, 2018-10, Vol.29, p.viii428-viii429

2018

Link zum Volltext

Verfügbarkeit prüfen

Si je me sens mieux, essaye d’être cool

La revue de medecine interne, 2016-09, Vol.37 (9), p.644-647

2016

Link zum Volltext

Verfügbarkeit prüfen

What else ? Dyspnée soudaine chez une femme de 45 ans

La revue de medecine interne, 2016-03, Vol.37 (3), p.212-214

2016

Link zum Volltext

Verfügbarkeit prüfen

What else? Sudden dyspnea in a 45-year-old woman

La revue de medecine interne, 2016-03, Vol.37 (3), p.212-214

2016

Link zum Volltext

Verfügbarkeit prüfen

Lymphocytic meningitis in a 70-year-old woman

La revue de medecine interne, 2016-09, Vol.37 (9), p.644-647

2016

Link zum Volltext

Verfügbarkeit prüfen

1070P Previous viral infections assessed by pan-virus phage immunoprecipitation sequencing (PhIP-Seq) predict response to immune checkpoint blockers (ICBs) in non-small cell lung cancer (NSCLC)

Annals of oncology, 2022-09, Vol.33, p.S1043

2022

Link zum Volltext

Verfügbarkeit prüfen

1659P The use of liquid biopsy in patients with advanced pancreatic cancer (PDAC) to guide enrollment in phase I clinical trials

Annals of oncology, 2023-10, Vol.34, p.S913-S914

2023

Link zum Volltext

Verfügbarkeit prüfen

2300P Clonal hematopoiesis of indeterminate potential (CHIP) in patients with advanced NSCLC treated with immune checkpoint blockers (ICB) as monotherapy: Analysis of the PREMIS study

Annals of oncology, 2023-10, Vol.34, p.S1176-S1177

2023

Link zum Volltext

Verfügbarkeit prüfen

140P Stereotactic radiotherapy improves disease control in oligoprogressive patients included in early clinical trials, with focus on NSCLC

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S119-S119

2023

Link zum Volltext

Verfügbarkeit prüfen

Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study

European journal of cancer (1990), 2022-01, Vol.160, p.134-139

2022

Link zum Volltext

Verfügbarkeit prüfen

2171P Incidence of adverse events in patients treated with a combination of immune checkpoint blockers and chemotherapy: A real life cohort

Annals of oncology, 2023-10, Vol.34, p.S1126-S1127

2023

Link zum Volltext

Verfügbarkeit prüfen

1694P Discovery of circulating biomarkers in COVID-19 patients undergoing anti-IL6R immunotherapy

Annals of oncology, 2020-09, Vol.31, p.S1000-S1001

2020

Link zum Volltext

Verfügbarkeit prüfen

11P Senescent immune phenotype (SIP) status that predicts resistance to immune checkpoint blockers (ICB) among CMV+ advanced non-small cell lung cancer (aNSCLC) patients is not associated with chronic type I IFN signature

Annals of oncology, 2021-12, Vol.32, p.S1379

2021

Link zum Volltext

Verfügbarkeit prüfen

L’hématopoïèse clonale : un concept émergent à la croisée des spécialités

La revue de medecine interne, 2019-10, Vol.40, p.684-692

2019

Link zum Volltext

Verfügbarkeit prüfen

516P Building a new prognostic score for patients with central nervous system (CNS) tumors enrolled in early phase clinical trials

Annals of oncology, 2023-10, Vol.34, p.S398-S398

2023

Link zum Volltext

Verfügbarkeit prüfen

2158P A self-assessment survey to identify the risk of patient’s screen fail in phase I clinical trials (SCITEP trial)

Annals of oncology, 2023-10, Vol.34, p.S1122-S1122

2023

Link zum Volltext

Verfügbarkeit prüfen

1845P Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?

Annals of oncology, 2023-10, Vol.34, p.S999-S1000

2023

Link zum Volltext

Verfügbarkeit prüfen

L’hématopoïèse clonale : un concept émergent à la croisée des spécialités

La revue de medecine interne, 2019-10, Vol.40 (10), p.684-692

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(51)
Französisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(11)
Humans
(9)
Oncology
(7)
Life Sciences
(5)
Female
(4)
Immunotherapy
(4)
Middle Aged
(4)
Aged
(3)
Cancer
(3)
General & Internal Medicine
(3)
Immune Checkpoint Inhibitors
(3)
Male
(3)
Medicine, General & Internal
(3)
Adult
(2)
Aged, 80 And Over
(2)
Bacteriology
(2)
Clonal Haematopoiesis Of Indeterminate Potential
(2)
Covid-19
(2)
Dntmt3a
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors

Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance

Impact of acetaminophen on the efficacy of immunotherapy in cancer patients

High levels of TNFα in patients with COVID-19 refractory to tocilizumab

Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy

Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?

Clonal haematopoiesis: A concise review

Incidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy

Si je me sens mieux, essaye d’être cool

What else ? Dyspnée soudaine chez une femme de 45 ans

What else? Sudden dyspnea in a 45-year-old woman

Lymphocytic meningitis in a 70-year-old woman

1070P Previous viral infections assessed by pan-virus phage immunoprecipitation sequencing (PhIP-Seq) predict response to immune checkpoint blockers (ICBs) in non-small cell lung cancer (NSCLC)

1659P The use of liquid biopsy in patients with advanced pancreatic cancer (PDAC) to guide enrollment in phase I clinical trials

2300P Clonal hematopoiesis of indeterminate potential (CHIP) in patients with advanced NSCLC treated with immune checkpoint blockers (ICB) as monotherapy: Analysis of the PREMIS study

140P Stereotactic radiotherapy improves disease control in oligoprogressive patients included in early clinical trials, with focus on NSCLC

Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study

2171P Incidence of adverse events in patients treated with a combination of immune checkpoint blockers and chemotherapy: A real life cohort

1694P Discovery of circulating biomarkers in COVID-19 patients undergoing anti-IL6R immunotherapy

11P Senescent immune phenotype (SIP) status that predicts resistance to immune checkpoint blockers (ICB) among CMV+ advanced non-small cell lung cancer (aNSCLC) patients is not associated with chronic type I IFN signature

L’hématopoïèse clonale : un concept émergent à la croisée des spécialités

516P Building a new prognostic score for patients with central nervous system (CNS) tumors enrolled in early phase clinical trials

2158P A self-assessment survey to identify the risk of patient’s screen fail in phase I clinical trials (SCITEP trial)

1845P Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?

L’hématopoïèse clonale : un concept émergent à la croisée des spécialités

Suchergebnisse filtern